Buy & Sell ZIM Integrated Shipping Services Ltd (ZIM) – ZIM Integrated Shipping Services Ltd Price Today
Aura AI Summary
Key Stats
- $3.05BMarket Cap
- IndustrialsSector
- -17.72%3M Drawdown
- $6.90BEnterprise Value
- 7.88%Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 21 daysTypical Hold Time
ZIM Integrated Shipping Services Ltd (ZIM) is currently valued at a market capitalization of $3.05B, with an enterprise value of $6.90B. Over the past 52 weeks, ZIM Integrated Shipping Services Ltd has traded between a low of $12.44 and a high of $29.27, highlighting its annual price range. Over the past three months, ZIM Integrated Shipping Services Ltd has recorded a drawdown of -17.72%, reflecting recent price volatility. ZIM Integrated Shipping Services Ltd offers a dividend yield of 7.88%. On average, investors hold ZIM Integrated Shipping Services Ltd for approximately 21 days, indicating typical investor behavior on the platform.
About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Most Recent News
Muskrat Dam First Nation connects to Ontario power grid, ending diesel reliance and enabling community growth.
Muskrat Dam First Nation in northern Ontario was connected to the provincial power grid on April 9, 2026, allowing the community to shut down costly diesel generators. This connection removes previous power constraints, enabling new construction proj...

ASE Technology sees AI chip demand boost but insider selling and high valuation raise caution.
ASE Technology Holding Co Ltd reported strong growth driven by demand for AI chip packaging, with gross margins rising to 20.1% from 16.8% year-over-year. The company expects its advanced packaging revenue to exceed $3.5 billion in 2026, reflecting r...

Over 20 pharma firms actively develop 25+ drugs for acute kidney injury treatment, signaling strong pipeline growth.
More than 20 pharmaceutical companies are actively researching and developing over 25 drugs for acute kidney injury (AKI), a condition causing sudden kidney function decline. Key players like AstraZeneca and Akebia Therapeutics are advancing therapie...
